Fundraising Fox

Outlook Therapeutics

NASDAQ: OTLK

Iselin, US · Delaware corporation · 1 known investors

outlooktherapeutics.com ↗
Biotechin /outlook-therapeutics@outlooktx

Founders & leadership

LA
Lawrence A. KenyonExecutive Officer, Director
JE
Jeff EvansonExecutive Officer
PM
Pankaj MohanExecutive Officer, Director
DG
Donald GriffithDirector
SC
Scott CanuteDirector
TB
Todd BradyDirector
FG
Faisal G. SukhtianDirector
YH
Yezan HaddadinDirector
AH
Andong HuangDirector
KJ
Kurt J. HilzingerDirector
JA
Julia A. HallerDirector
GA
Gerd AuffarthDirector

Investors · 1

Avoro Capital AdvisorsNew York

Reported raises · per SEC filings

Form D private placements
▶$5MofferedMay 2026 · 2 investors · Biotechnology
Rule 506(b)
Outlook Therapeutics to Report Q3 Earnings: What's in the Cards?finance.yahoo.com · Aug 2026Outlook Therapeutics (OTLK) Stock Looks Cheap On Hope But Pricey On Book Value - Simply Wall St Newssimplywall.st · Jul 2026
Officers, directors & promoters on the filing
  • Yezan HaddadinDirector
  • Lawrence A. KenyonExecutive Officer, Director
  • Faisal G. SukhtianDirector
  • Randy H. ThurmanDirector
  • Julian GangolliDirector
  • Kurt J. HilzingerDirector
  • Gerd AuffarthDirector
  • Andong HuangDirector
Offering amount
$5M
Finders' fees
$485K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Apr 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$32MofferedJan 2025 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence A. KenyonExecutive Officer, Director
  • Jeff EvansonExecutive Officer
  • Faisal G. SukhtianDirector
  • Julia A. HallerDirector
  • Gerd AuffarthDirector
  • Yezan HaddadinDirector
  • Randy H. ThurmanDirector
  • Julian GangolliDirector
  • Andong HuangDirector
  • Kurt J. HilzingerDirector
Offering amount
$32M
Finders' fees
$1.4M
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedApr 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff EvansonExecutive Officer
  • Julia A. HallerDirector
  • Julian GangolliDirector
  • Gerd AuffarthDirector
  • Andong HuangDirector
  • C. Russell TrenaryExecutive Officer, Director
  • Lawrence A. KenyonExecutive Officer, Director
  • Kurt J. HilzingerDirector
  • Yezan HaddadinDirector
  • Randy H. ThurmanDirector
  • Faisal G. SukhtianDirector
Offering amount
$13.3M
Amount sold
$5M
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$60MraisedMar 2024 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff EvansonExecutive Officer
  • Andong HuangDirector
  • Julia A. HallerDirector
  • Kurt J. HilzingerDirector
  • Lawrence A. KenyonExecutive Officer, Director
  • Julian GangolliDirector
  • Gerd AuffarthDirector
  • Faisal G. SukhtianDirector
  • Randy H. ThurmanDirector
  • C. Russell TrenaryExecutive Officer, Director
  • Yezan HaddadinDirector
Offering amount
$159M
Amount sold
$60M
Finders' fees
$3.6M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedJan 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Randy H. ThurmanDirector
  • Andong HuangDirector
  • Yezan HaddadinDirector
  • Julia A. HallerDirector
  • Gerd AuffarthDirector
  • Julian GangolliDirector
  • Lawrence A. KenyonExecutive Officer, Director
  • Faisal G. SukhtianDirector
  • C. Russell TrenaryExecutive Officer, Director
  • Kurt J. HilzingerDirector
Offering amount
$1M
Amount sold
$1M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$31.8MraisedJan 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Julia A. HallerDirector
  • Andong HuangDirector
  • C. Russell TrenaryExecutive Officer, Director
  • Randy H. ThurmanDirector
  • Julian GangolliDirector
  • Lawrence A. KenyonExecutive Officer, Director
  • Faisal G. SukhtianDirector
  • Gerd AuffarthDirector
  • Yezan HaddadinDirector
  • Kurt J. HilzingerDirector
Offering amount
$31.8M
Amount sold
$31.8M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedFeb 2021 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Julian GangolliDirector
  • Randy ThurmanDirector
  • Yezan HaddadinDirector
  • Kurt J. HilzingerDirector
  • Lawrence A. KenyonExecutive Officer, Director
  • Faisal G. SukhtianDirector
  • Andong HuangDirector
  • Gerd AuffarthDirector
Offering amount
$4M
Amount sold
$4M
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16MraisedJun 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Julian GangolliDirector
  • Kurt J. HilzingerDirector
  • Randy ThurmanDirector
  • Lawrence A. KenyonExecutive Officer, Director
  • Jeff EvansonExecutive Officer
  • Faisal G. SukhtianDirector
  • Yezan HaddadinDirector
  • Gerd AuffarthDirector
  • Terry DagnonExecutive Officer
Offering amount
$16M
Amount sold
$16M
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news